← SynDRA
XMD-892
SynDRA canonical compound SYN0058312 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | MAPK7 |
|---|
| Mechanism of action | MAP kinase inhibitor |
|---|
All known targets
- MAPK7
- DCLK2
- PLK4
- TNK1
- LRRK2
Mechanisms of action (all sources)
- MEK inhibitor
- DCLK2 INHIBITOR
- MAPK7 INHIBITOR
- PLK4 INHIBITOR
- TNK1 INHIBITOR
Cross-references
Synonyms
- XMD 8-92
- XMD8-92
- Xmd8-92
- XMD-8-92
- CHEBI:60325
- RefChem:934336
- MFCD18782742
- 4WG
- Scaffold, B46
- MLS003230939
- SCHEMBL619295
- GTPL8057
- orb1307342
- SCHEMBL29356878
- SCHEMBL29372331
- EX-A999
- GLXC-05933
- HMS3295A13
- HMS3653F13
- XMD8-92?
- BDBM50337134
- s7525
- AKOS024457992
- CCG-269488
- CS-0245
- SB19429
- NCGC00250385-01
- NCGC00250385-02
- NCGC00250385-09
- NCGC00250385-11
- AC-35690
- AS-75126
- BP-25377
- DA-46979
- HY-14443
- SMR001913504
- SY346687
- XMD8-92, >=98% (HPLC)
- SW209502-2
Look up XMD-892 in the interactive SynDRA portal →